How to Vet a Research Peptide Supplier in 2027: A Checklist, and What the Closures Changed

Why this guide exists#

2026 removed several of the largest research peptide suppliers from the market within a few months of one another. Laboratories that had relied on a single source are now evaluating new ones, and search results for "alternative" suppliers are dominated by thin pages that rank a handful of stores without saying how they were judged. This guide does the opposite: it gives the questions, in order, and the public sources a buyer can check for any supplier, including Renuvia Labs.

What happened in 2027, briefly and from the record#

The following is limited to what the companies themselves or primary sources have stated. Dates are as published.

• January 2026 — Science.bio announced its closure.
• 6 March 2026 — Peptide Sciences posted a notice that it had "decided to voluntarily shut down operations." The same notice warns that anyone claiming to be a successor or affiliate is unauthorized.
• 8 September 2026 — Chemyo closed.
• 27 September 2026 — Chameleon Peptides announced a wind-down, citing new requirements from card networks and acquiring banks about who may be sold to and how buyers are verified.
• August 2026 — The owner of a separate supplier was sentenced in U.S. federal court after admitting that laboratory certificates supplied to customers had been forged.
• 2025–2026 — FDA issued warning letters to a series of research-use-only peptide sellers, quoting product-page and FAQ copy as evidence that products were being marketed for human use despite "research use only" labels.

Three lessons follow directly from the record. In-house paperwork is not the same as independent evidence, because a certificate can be fabricated. Payment processing, not demand, is what closed several of these businesses, so a supplier's checkout posture now tells you something about its durability. And the brands that closed are being impersonated, so a familiar name is no longer a reason to skip verification.

The checklist#

Work through these in order. Each item names something you can check without taking the supplier's word for it.

1. Is there independent test data for this supplier at all?#

Mail-in testing services publish results per vendor and per product, with pass and fail counts. A supplier with published independent results, including some failures, has a track record you can read. A supplier with none has only its own claims. Look up the supplier on an independent testing database before reading its website.

2. Does each lot have its own Certificate of Analysis, and does the certificate name the laboratory?#

A COA is evidence about one production lot, not about a product name. The things to look for on the certificate:

• a lot number that matches the vial label;
• the name of the laboratory that performed the tests;
• the test date and the methods used (HPLC for purity, mass spectrometry for identity, with the column, gradient and instrument stated);
• the results, including anything that was not tested.

A single purity image in a product gallery, with no lot number and no laboratory named, does not meet this standard. Neither does a purity figure printed on a label.

3. Is the supplier honest about what it has not yet tested?#

A new supplier will not have reports for every lot on day one. The question is whether it says so. "Batch report pending" on a product page is a verifiable statement; "99% pure" on a page with no report behind it is not. Treat a gap that is disclosed differently from a gap that is hidden.

4. Can you trace the vial to the lot and the lot to the documentation?#

Ask how lots are numbered, where the number appears on the vial, and whether old lots' reports stay published after the lot sells out. A supplier that archives its COAs lets you check material you already have on the bench.

5. What does the product page say about use?#

FDA's 2024–2026 warning letters to research peptide sellers quote product-page copy describing effects in people, dosing guides, "test subject" euphemisms and calculators. A supplier whose pages read like a drug label is one whose pages regulators have already said they read as drug marketing. For a laboratory buyer, that is a continuity risk as much as a compliance one: it is the posture that preceded several of this year's closures.

6. How does checkout work, and who is the supplier willing to sell to?#

Card networks now expect research suppliers to verify that buyers are laboratories, institutions or research businesses. A supplier that asks who you are, offers quote-based ordering for larger quantities, and states its accepted payment methods plainly is behaving the way payment processors describe a legitimate research supplier. A supplier that relies on a checkbox, or asks for personal payment apps, is carrying the risk that closed others.

7. Are the company's identity and contact details consistent across the web?#

Check that the supplier's name, website, support email and profiles (business listings, review platforms, social accounts) agree with one another. Closed brands have published explicit warnings that successors and look-alikes using their names are fraudulent; a new store using a familiar name, a mail-drop address and crypto-only payment is the pattern those warnings describe.

8. Does the supplier publish failures?#

The strongest signal available in this market is a supplier that publishes a failed lot report and says what it did about it. Nobody is obliged to do this. The ones that do are showing you their process, not their marketing.

How Renuvia Labs measures against this checklist today#

Stated as facts about this site on the date of publication, not as claims of superiority.

Readers are encouraged to apply the same table to any supplier, including this one, and to update it as reports are published.

Related reading#

• How to read a Certificate of Analysis
• HPLC and mass spectrometry explained
• Peptide quality and testing standards
• COA library